Biomarker aids asthma control in pregnant women
Algorithm leads to fewer exacerbations in those with non-eosinophilic disease, researchers say
An algorithm based on exhaled nitric oxide leads to fewer exacerbations in pregnant women with non-eosinophilic asthma than responding to symptoms alone, an Australian study shows.
Researchers led by Professor Peter Gibson from the University of Newcastle and John Hunter Hospital, have demonstrated how to optimise treatment for this group in a reanalysis of data from the Australian Managing Asthma in Pregnancy (MAP) trial reported in the Lancet in 2011.
